NEW YORK – IsoPlexis said today that it has entered an exclusive agreement with BioStream to distribute its single-cell protein analysis products in Japan.
The Branford, Connecticut-based firm's IsoCode and IsoLight products enable highly multiplexed protein measurements at the single-cell level and have seen uptake in several research areas, particularly in cancer immunotherapy.